A radiomics-based model for predicting prognosis of locally advanced gastric cancer in the preoperative setting

被引:43
作者
Shin, Jaeseung [1 ,2 ]
Lim, Joon Seok [1 ,2 ]
Huh, Yong-Min [1 ,2 ]
Kim, Jie-Hyun [3 ]
Hyung, Woo Jin [4 ]
Chung, Jae-Joon [5 ]
Han, Kyunghwa [1 ,2 ]
Kim, Sungwon [1 ,2 ]
机构
[1] Yonsei Univ, Severance Hosp, Dept Radiol, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea
[2] Yonsei Univ, Severance Hosp, Res Inst Radiol Sci, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea
[3] Yonsei Univ, Gangnam Severance Hosp, Dept Internal Med, Coll Med, Seoul, South Korea
[4] Yonsei Univ, Dept Surg, Coll Med, Seoul, South Korea
[5] Yonsei Univ, Gangnam Severance Hosp, Dept Radiol, Coll Med, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
CT TEXTURE ANALYSIS; PERIOPERATIVE CHEMOTHERAPY; COMPUTED-TOMOGRAPHY; TUMOR HETEROGENEITY; SURGERY; ADENOCARCINOMA; CAPECITABINE; REGRESSION; THERAPY;
D O I
10.1038/s41598-021-81408-z
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
This study aims to evaluate the performance of a radiomic signature-based model for predicting recurrence-free survival (RFS) of locally advanced gastric cancer (LAGC) using preoperative contrast-enhanced CT. This retrospective study included a training cohort (349 patients) and an external validation cohort (61 patients) who underwent curative resection for LAGC in 2010 without neoadjuvant therapies. Available preoperative clinical factors, including conventional CT staging and endoscopic data, and 438 radiomic features from the preoperative CT were obtained. To predict RFS, a radiomic model was developed using penalized Cox regression with the least absolute shrinkage and selection operator with ten-fold cross-validation. Internal and external validations were performed using a bootstrapping method. With the final 410 patients (58.2 +/- 13.0 years-old; 268 female), the radiomic model consisted of seven selected features. In both of the internal and the external validation, the integrated area under the receiver operating characteristic curve values of both the radiomic model (0.714, P<0.001 [internal validation]; 0.652, P=0.010 [external validation]) and the merged model (0.719, P<0.001; 0.651, P=0.014) were significantly higher than those of the clinical model (0.616; 0.594). The radiomics-based model on preoperative CT images may improve RFS prediction and high-risk stratification in the preoperative setting of LAGC.
引用
收藏
页数:12
相关论文
共 39 条
[1]   The Potential of Radiomic-Based Phenotyping in PrecisionMedicine A Review [J].
Aerts, Hugo J. W. L. .
JAMA ONCOLOGY, 2016, 2 (12) :1636-1642
[2]   Survival and prognosticators of gastric cancer that recurs after adjuvant chemotherapy with S-1 [J].
Aoyama, Toru ;
Yoshikawa, Takaki ;
Watanabe, Takafumi ;
Hayashi, Tsutomu ;
Ogata, Takashi ;
Cho, Haruhiko ;
Tsuburaya, Akira .
GASTRIC CANCER, 2011, 14 (02) :150-154
[3]   Radiomic MRI Phenotyping of Glioblastoma: Improving Survival Preciction [J].
Bae, Sohi ;
Choi, Yoon Seong ;
Ahn, Sung Soo ;
Chang, Jong Hee ;
Kang, Seok-Gu ;
Kim, Eui Hyun ;
Kim, Se Hoon ;
Lee, Seung-Koo .
RADIOLOGY, 2018, 289 (03) :797-806
[4]   Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial [J].
Bang, Yung-Jue ;
Kim, Young-Woo ;
Yang, Han-Kwang ;
Chung, Hyun Cheol ;
Park, Young-Kyu ;
Lee, Kyung Hee ;
Lee, Keun-Wook ;
Kim, Yong Ho ;
Noh, Sang-Ik ;
Cho, Jae Yong ;
Mok, Young Jae ;
Kim, Yeul Hong ;
Ji, Jiafu ;
Yeh, Ta-Sen ;
Button, Peter ;
Sirzen, Florin ;
Noh, Sung Hoon .
LANCET, 2012, 379 (9813) :315-321
[5]   Quantitative Assessment of Rectal Cancer Response to Neoadjuvant Combined Chemotherapy and Radiation Therapy: Comparison of Three Methods of Positioning Region of Interest for ADC Measurements at Diffusion-weighted MR Imaging [J].
Blazic, Ivana M. ;
Lilic, Gordana B. ;
Gajic, Milan M. .
RADIOLOGY, 2017, 282 (02) :418-+
[6]  
Boige V, 2007, J CLIN ONCOL, V25
[7]   Patterns of regional recurrence after curative D2 resection for stage III (N3) gastric cancer: Implications for postoperative radiotherapy [J].
Chang, Jee Suk ;
Lim, Joon Seok ;
Noh, Sung Hoon ;
Hyung, Woo Jin ;
An, Ji Yeong ;
Lee, Yong Chan ;
Rha, Sun Young ;
Lee, Chang Geol ;
Koom, Woong Sub .
RADIOTHERAPY AND ONCOLOGY, 2012, 104 (03) :367-373
[8]   Perioperative chemotherapy for resectable gastric cancer: MAGIC and beyond [J].
Choi, Audrey H. ;
Kim, Joseph ;
Chao, Joseph .
WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (24) :7343-7348
[9]   Histopathological regression of gastric adenocarcinoma after neoadjuvant therapy: a critical review [J].
Cunha Neves Filho, Eduardo Henrique ;
de Sant'Ana, Rosane Oliveira ;
Saldanha Cidrao Nunes, Luiz Vianney ;
Bezerra Pires, Adriana Pinheiro ;
Socorro Saldanha da Cunha, Maria do Perpetuo .
APMIS, 2017, 125 (02) :79-84
[10]   Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer [J].
Cunningham, David ;
Allum, William H. ;
Stenning, Sally P. ;
Thompson, Jeremy N. ;
Van de Velde, Cornelis J. H. ;
Nicolson, Marianne ;
Scarffe, J. Howard ;
Lofts, Fiona J. ;
Falk, Stephen J. ;
Iveson, Timothy J. ;
Smith, David B. ;
Langley, Ruth E. ;
Verma, Monica ;
Weeden, Simon ;
Chua, Yu Jo .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (01) :11-20